Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 8, 2019
Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid
Philip M Sobolesky, Breland E Smith, Jacqueline A Hubbard, et al.
Clinical Chemistry
|
November 12, 2025
Per Se Driving Under the Influence of Cannabis Statutes and Blood Delta-9-Tetrahydrocannabinol Concentrations following Short-Term Cannabis Abstinence
Robert L Fitzgerald, Anya Umlauf, Raymond T Suhandynata, et al.
The Journal of Applied Laboratory Medicine
|
June 4, 2024
A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection
K H Brian Lam, Marlen Menlyadiev, Vincent Buggs, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 1, 2020
The 99th percentile upper reference limit for the 5th generation cardiac troponin T assay in the United States
Robert L Fitzgerald, Judd E Hollander, W Frank Peacock, et al.
Clinical Chemistry
|
September 6, 2005
41Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal disease patients
Robert L Fitzgerald, Darren J Hillegonds, Douglas W Burton, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 3, 2015
Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI
Nandkishor S Chindarkar, Lakhmir S Chawla, Joely A Straseski, et al.
Data in Brief
|
December 25, 2015
Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
Nandkishor S Chindarkar, Lakhmir S Chawla, Joely A Straseski, et al.
Psychopharmacology
|
September 5, 2025
Short-term residual effects of smoked cannabis on simulated driving performance
Kyle F Mastropietro, Jake A Rattigan, Anya Umlauf, et al.
JAMA Psychiatry
|
August 2, 2023
Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial
Thomas D Marcotte, Anya Umlauf, David J Grelotti, et al.
Clinical Chemistry and Laboratory Medicine
|
January 23, 2026
Comparison of six serum analyte workflows using routine liquid chromatography-tandem mass spectrometry methods at multiple laboratories with the Cobas i 601 analyzer, an automated mass spectrometry system
Pieter Vermeersch, Robert de Jonge, Takamaro Miyazawa, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 8, 2019
Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid
Philip M Sobolesky, Breland E Smith, Jacqueline A Hubbard, et al.
Clinical Chemistry
|
November 12, 2025
Per Se Driving Under the Influence of Cannabis Statutes and Blood Delta-9-Tetrahydrocannabinol Concentrations following Short-Term Cannabis Abstinence
Robert L Fitzgerald, Anya Umlauf, Raymond T Suhandynata, et al.
The Journal of Applied Laboratory Medicine
|
June 4, 2024
A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection
K H Brian Lam, Marlen Menlyadiev, Vincent Buggs, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 1, 2020
The 99th percentile upper reference limit for the 5th generation cardiac troponin T assay in the United States
Robert L Fitzgerald, Judd E Hollander, W Frank Peacock, et al.
Clinical Chemistry
|
September 6, 2005
41Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal disease patients
Robert L Fitzgerald, Darren J Hillegonds, Douglas W Burton, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
November 3, 2015
Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI
Nandkishor S Chindarkar, Lakhmir S Chawla, Joely A Straseski, et al.
Data in Brief
|
December 25, 2015
Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
Nandkishor S Chindarkar, Lakhmir S Chawla, Joely A Straseski, et al.
Psychopharmacology
|
September 5, 2025
Short-term residual effects of smoked cannabis on simulated driving performance
Kyle F Mastropietro, Jake A Rattigan, Anya Umlauf, et al.
JAMA Psychiatry
|
August 2, 2023
Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial
Thomas D Marcotte, Anya Umlauf, David J Grelotti, et al.
Clinical Chemistry and Laboratory Medicine
|
January 23, 2026
Comparison of six serum analyte workflows using routine liquid chromatography-tandem mass spectrometry methods at multiple laboratories with the Cobas i 601 analyzer, an automated mass spectrometry system
Pieter Vermeersch, Robert de Jonge, Takamaro Miyazawa, et al.
Page
of 9